ArticleESMO gastrointestinal oncology2025

Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2).

T Shirakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.